Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis

International Journal for Parasitology

Volumn 41, Issue 3, 2011, Pages 463-469

  Elshafie, Amir I ^a,b   Åhlin, Erik ^a   Håkansson, Lena Douhan ^a   Elghazali, Gehad ^c,d   Safi, Sayda Hassan El ^d   Rönnelid, Johan ^a   Venge, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Alribat University Hospital   (Sudan)

^c KING FAHAD MEDICAL CITY   (Saudi Arabia)

^d UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

Eosinophil; Eosinophil cationic protein; Leishmania donovani; Myeloperoxidase; Neutrophil; Parasite

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 5; INTERLEUKIN 8; MYELOPEROXIDASE;

BIOASSAY; BLOOD; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; EXPERIMENTAL STUDY; LABORATORY METHOD; PLASMA; PROTEIN; SECRETION;

ADULT; ARTICLE; BLOOD SAMPLING; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BLOOD LEVEL; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL COUNT; PROTEIN BLOOD LEVEL; RURAL AREA; SUDAN; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANIMALS; CHILD; CYTOKINES; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; GRANULOCYTES; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PEROXIDASE; SUDAN; SWEDEN; YOUNG ADULT;

SUDAN;

LEISHMANIA DONOVANI;

EID: 79951812033     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.11.005     Document Type: Article

References (42)

1. Aga E., Katschinski D.M., van Z.G., Laufs H., Hansen B., Muller K., Solbach W., Laskay T. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J. Immunol. 2002, 169:898-905.
2. Badaro R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., Teixeira R., Johnson W.D. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 1986, 154:1003-1011.
3. Badaro R., Jones T.C., Lorenco R., Cerf B.J., Sampaio D., Carvalho E.M., Rocha H., Teixeira R., Johnson W.D. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J. Infect. Dis. 1986, 154:639-649.
4. Badolato R., Sacks D.L., Savoia D., Musso T. Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Exp. Parasitol. 1996, 82:21-26.
5. Beil W.J., Meinardus-Hager G., Neugebauer D.C., Sorg C. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J. Leukoc. Biol. 1992, 52:135-142.
6. Bjork A., Venge P., Peterson C.G. Measurements of ECP in serum and the impact of plasma coagulation. Allergy 2000, 55:442-448.
7. bu-Ghazaleh R.I., Kita H., Gleich G.J. Eosinophil activation and function in health and disease. Immunol. Ser. 1992, 57:137-167.
8. Chang K.P. Leishmanicidal mechanisms of human polymorphonuclear phagocytes. Am. J. Trop. Med. Hyg. 1981, 30:322-333.
9. Charmoy M., Auderset F., Allenbach C., Tacchini-Cottier F. The prominent role of neutrophils during the initial phase of infection by Leishmania parasites. J. Biomed. Biotechnol. 2010, 2010:719361.
10. Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., Williams T.J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 1995, 182:1169-1174.
11. Cotterell S.E., Engwerda C.R., Kaye P.M. Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha. Blood 2000, 95:1642-1651.
12. Desjeux P. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 1996, 14:417-423.
13. Dvorak A.M., Klebanoff S.J., Henderson W.R., Monahan R.A., Pyne K., Galli S.J. Vesicular uptake of eosinophil peroxidase by guinea pig basophils and by coloned mouse mast cells and granule-containing lymphoid cells. Am. J. Pathol. 1985, 118:425-438.
14. ElShafie A.I., Ahlin E., Mathsson L., Elghazali G., Ronnelid J. Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in Sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. J. Immunol. 2007, 178:5383-5389.
15. Elsner J., Höchstetter R., Kimmig D., Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur. J. Immunol. 1996, 26:1919-1925.
16. Ezra N., Ochoa M.T., Craft N. Human immunodeficiency virus and leishmaniasis. J. Glob. Infect. Dis. 2010, 2:248-257.
17. Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., Celestin J., Leder P., Luster A.D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 1996, 2:449-456.
18. Gupta K.K., Hoon R.S. Tropical eosinophilia and intestinal parasites. Indian J. Chest Dis. 1971, 13:163-169.
19. Hoogstraal H., Heyneman D. Leishmaniasis in the Sudan Republic. 30. Final report. Am. J. Trop. Med. Hyg. 1969, 18:1091-1210.
20. Jochim R.C., Teixeira C. Leishmania commandeers the host inflammatory response through neutrophils. Trends Parasitol. 2009, 25:145-147.
21. John B., Hunter C.A. Immunology. Neutrophil soldiers or Trojan Horses?. Science 2008, 321:917-918.
22. Kay A.B. Eosinophils: role in asthma, allergy and parasite immunity. N. Engl. Reg. Allergy Proc. 1985, 6:341-345.
23. Lampinen M., Carlson M., Hakansson L.D., Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004, 59:793-805.
24. Lampinen M., Rak S., Venge P. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin. Exp. Allergy 1999, 29:314-322.
25. Laskay T., van Z.G., Solbach W. Neutrophil granulocytes - Trojan horses for Leishmania major and other intracellular microbes?. Trends Microbiol. 2003, 11:210-214.
26. Loscher T., Saathoff E. Eosinophilia during intestinal infection. Best. Pract. Res. Clin. Gastroenterol. 2008, 22:511-536.
27. Manson-Bahr P.E. Immunity in kala-azar. Trans. R. Soc. Trop. Med. Hyg. 1961, 55:550-555.
28. Mawhorter S.D. Eosinophilia caused by parasites. Pediatr. Ann. 1994, 23(405):409-405, 413.
29. Oliveira S.H., Fonseca S.G., Romao P.R., Figueiredo F., Ferreira S.H., Cunha F.Q. Microbicidal activity of eosinophils is associated with activation of the arginine-NO pathway. Parasite Immunol. 1998, 20:405-412.
30. Pearson R.D., Sousa A.Q. Clinical spectrum of Leishmaniasis. Clin. Infect. Dis. 1996, 22:1-13.
31. Pearson R.D., Steigbigel R.T. Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes. J. Immunol. 1981, 127:1438-1443.
32. Pearson R.D., Uydess I.L., Chapman S.W., Steigbigel R.T. Interaction of human eosinophils with Leishmania donovani. Ann. Trop. Med. Parasitol. 1987, 81:735-739.
33. Peters N.C., Egen J.G., Secundino N., Debrabant A., Kimblin N., Kamhawi S., Lawyer P., Fay M.P., Germain R.N., Sacks D. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 2008, 321:970-974.
34. Pollack S., Nagler A., Liberman D., Oren I., Alroy G., Katz R., Schechter Y. Immunological studies of pancytopenia in visceral leishmaniasis. Isr. J. Med. Sci. 1988, 24:70-74.
35. Rundstrom G., Jonsson A., Martensson O., Mendel-Hartvig I., Venge P. Lateral flow immunoassay using europium (III) chelate microparticles and time-resolved fluorescence for eosinophils and neutrophils in whole blood. Clin. Chem. 2007, 53:342-348.
36. Seaman J., Mercer A.J., Sondorp E. The epidemic of visceral leishmaniasis in Western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int. J. Epidemiol. 1996, 25:862-871.
37. Southgate B.A., Manson-Bahr P.E. Studies in the epidemiology of East African leishmaniasis. 4. The significance of the positive leishmanin test. J. Trop. Med. Hyg. 1967, 70:29-33.
38. Venge P. Monitoring the allergic inflammation. Allergy 2004, 59:26-32.
39. Venge P., Bystrom J., Carlson M., Hakansson L., Karawacjzyk M., Peterson C., Seveus L., Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin. Exp. Allergy 1999, 29:1172-1186.
40. Wachtfogel Y.T., Kucich U., James H.L., Scott C.F., Schapira M., Zimmerman M., Cohen A.B. Human plasma kallikrein releases neutrophil elastase during blood coagulation. J. Clin. Invest. 1983, 72:1672-1677.
41. Zijlstra E.E., el-Hassan A.M., Ismael A., Ghalib H.W. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am. J. Trop. Med. Hyg. 1994, 51:826-836.
42. Zijlstra E.E., Musa A.M., Khalil E.A., el-Hassan I.M., el-Hassan A.M. Post-kala-azar dermal leishmaniasis. Lancet Infect. Dis. 2003, 3:87-98.